Palvella Therapeutics, Inc. (PVLA) vs Trevi Therapeutics, Inc. (TRVI)
A side-by-side comparison of Palvella Therapeutics, Inc. and Trevi Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PVLA
Palvella Therapeutics, Inc.
$130.22HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
TRVI
Trevi Therapeutics, Inc.
$13.42HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — PVLA vs TRVI
growth of $100 · dividends reinvested · last 2yPVLA +677.4% (+178.8%/yr)TRVI +415.8% (+127.1%/yr)PVLA compounded faster over this window
PVLA TRVI
PVLA vs TRVI: by the numbers
- •TRVI is the larger company ($1.91B vs $1.87B market cap).
Metrics side by side
Valuation
| Metric | PVLA | TRVI |
|---|---|---|
| P/B ratio | 8.61 | 5.93 |
Profitability
| Metric | PVLA | TRVI |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -28.45% | -15.90% |
| ROIC | -23.90% | -18.51% |
Growth (annualized)
| Metric | PVLA | TRVI |
|---|---|---|
| Total return CAGR (5Y) | N/A | 61.74% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.